查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1891798

全球胸廓出口症候群市場：依應用類型、應用、產品類型、最終用戶、技術/作用機制和地區劃分－市場規模、產業趨勢、機會分析和預測（2026-2035 年）

Global Thoracic Outlet Syndrome Market: By Deployment Type, Application, Product Type, End-User, Technology/Mode of Action, Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 280 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

胸廓出口症候群市場目前正處於強勁增長期，預計到 2025 年將達到約 2.347 億美元。這一成長趨勢預計將在未來十年持續強勁，到 2035 年將達到 4.233 億美元。 2026 年至 2035 年的複合年增長率 (CAGR) 為 6.1%，反映了對有效診斷和治療方案的持續增長的需求。

推動這一令人矚目的市場擴張的幾個關鍵因素是：大眾和醫療專業人員對胸廓出口症候群的認識不斷提高，有助於提高診斷率，使更多患者能夠在正確的時間獲得正確的治療。此外，相關問題（例如重複性勞損和創傷）的發生率不斷上升，也推動了治療需求的成長。這些疾病通常會加劇或模擬胸廓出口症候群的症狀，因此需要更全面的篩檢和介入。

市場趨勢

在胸廓出口症候群 (TOS) 領域，多家領先企業和醫療機構在提供專業護理和推進治療方面發揮關鍵作用。梅奧診所、約翰霍普金斯醫院、阿波羅醫院和麻省總醫院布萊根醫院等知名醫療機構已設立專注於 TOS 的專科診所，為患者提供專業的、多學科團隊的護理。這些中心將臨床專業知識與先進技術相結合，提供全面的診斷和治療服務，以控制與神經和血管受壓相關的複雜症狀。

除了醫院護理外，像 Portea Medical 這樣的家庭醫療保健服務提供者也透過在患者家中提供便利的持續護理，為胸廓出口症候群 (TOS) 的管理做出了重大貢獻。這些服務支持持續的物理治療、監測和復健工作，這對需要在臨床環境之外進行長期管理的患者至關重要。

像 Fix Health 這樣的數位健康平台也正在成為 TOS 市場的重要參與者。這些平台利用科技提供遠距諮詢、治療指導和病患教育，使患者更容易積極參與治療計劃並追蹤進度。

核心成長驅動因子

截至 2025 年，胸廓出口症候群領域正在快速擴張。這主要是由於越來越多的慢性肩頸疼痛病例被重新歸類為明確的胸廓出口症候群診斷。這種轉變反映了人們對該疾病的更深入了解，以及醫療保健提供者對過去被模糊診斷所忽略的症狀的根本原因的認識不斷提高。隨著越來越多的患者獲得準確診斷，對標靶治療和專業護理的需求也相應增加，從而推動了市場顯著成長。

新機遇

透過超音波導引註射肉毒桿菌毒素進行精準肌肉標靶治療已成為推動胸廓出口症候群 (THS) 市場成長的關鍵趨勢。這種創新方法結合了肉毒桿菌毒素的治療優勢和超音波成像的精確性，使臨床醫生能夠將藥物精準注射到受影響的肌肉。透過靶向導致 THS 中神經和血管受壓的特定肌肉群，該方法提高了治療效果，同時最大限度地減少了與靶向不佳方法相關的潛在副作用。

優化障礙

早期誤診率高是有效治療 THS 的一大挑戰，這可能會嚴重阻礙市場成長。由於THS的症狀常常與其他肌肉骨骼和神經系統疾病的症狀重疊，許多患者在確診過程中會遇到延誤。這種診斷的複雜性通常需要患者接受多次諮詢和檢查才能正確確診，這可能會延長開始適當治療所需的時間。

目錄

第一章：摘要整理：全球胸廓出口症候群市場

第二章：研究方法與架構

  • 研究目標
  • 產品概述
  • 市場區隔
  • 質性研究
    • 一手和二手資料來源
  • 量化研究
    • 一手和二手資料來源
  • 依地區劃分的原始調查受訪者
  • 研究假設
  • 市場規模估算
  • 資料三角驗證

第三章：全球胸廓出口症候群市場概述

  • 產業價值鏈分析
    • 原料供應商
    • 製造商
    • 經銷商
    • 終端用戶
  • 行業展望
  • PESTLE 分析
  • 波特五力分析
    • 供應商議價能力
    • 買方議價能力
    • 替代品威脅
    • 新進入者威脅
    • 競爭強度
  • 市場成長與展望
    • 市場收入預測（2020-2035）
    • 價格趨勢分析
  • 市場吸引力分析
    • 依細分市場/地區劃分
    • 可操作的洞見（分析師建議）

第四章 競爭格局儀錶板

  • 市場集中度
  • 依公司劃分的市佔率分析（價值，2025 年）
  • 競爭格局分析與基準分析

第五章：全球胸廓出口症候群市場分析

  • 市場動態與趨勢
    • 成長推動因素
    • 限制因素
    • 機遇
    • 主要趨勢
  • 市場規模與預測（2020-2035 年）
    • 依產品類型劃分
    • 依部署類型劃分
    • 依應用程式劃分
    • 依技術劃分
    • 依最終用戶劃分
    • 依地區劃分

第六章：北美胸廓出口症候群市場分析

第七章：歐洲胸廓出口症候群市場分析

第八章：亞太地區胸廓出口症候群市場分析

第九章：中東與非洲胸廓出口症候群市場分析

第十章：南美洲胸廓出口症候群市場分析

第十一章：公司簡介

  • AngioDynamics
  • 貝克頓‧迪金森 (BD)
  • 波士頓科學
  • 佳能醫療系統
  • 富士軟片醫療
  • 通用電氣醫療
  • 強生 (DePuy Synthes)
  • 美敦力
  • 邁瑞
  • 飛利浦醫療保健
  • 西門子醫療
  • 史密斯和內普
  • 史賽克
  • 泰爾茂株式會社
  • 捷邁生物
  • 其他主要參與者

第十二章附錄

簡介目錄
Product Code: AA12251609

The thoracic outlet syndrome market is currently experiencing a period of robust expansion, with its valuation reaching approximately US$ 234.7 million in 2025. This upward trajectory is expected to continue strongly over the next decade, with projections estimating the market will grow to US$ 423.3 million by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2026 to 2035, reflecting sustained and increasing demand for effective diagnosis and treatment options.

Several key factors are driving this impressive market expansion. Increased awareness about thoracic outlet syndrome among both the general public and healthcare providers is helping to boost diagnosis rates, ensuring more patients receive timely and appropriate care. Additionally, the rising incidence of related issues, such as repetitive motion injuries and trauma, is contributing to greater demand for treatment. These conditions often exacerbate or mimic TOS symptoms, prompting more thorough screening and intervention.

Noteworthy Market Developments

In the Thoracic Outlet Syndrome (TOS) landscape, several key companies and healthcare providers play pivotal roles in delivering specialized care and driving advancements in treatment. Renowned institutions such as the Mayo Clinic, Johns Hopkins, Apollo Hospitals, and Mass General Brigham have established dedicated clinics focused on TOS, providing patients with access to expert multidisciplinary teams. These centers offer comprehensive diagnostic and therapeutic services, combining clinical expertise with advanced technologies to manage the complex symptoms associated with nerve and vascular compression.

In addition to hospital-based care, home healthcare service providers like Portea Medical contribute significantly to the management of TOS by offering convenient and continuous care in the patient's own environment. These services support ongoing physical therapy, monitoring, and rehabilitation efforts, which are critical for patients requiring long-term management outside of clinical settings.

Digital health platforms such as Fix Health are also emerging as important players in the TOS market. By leveraging technology, these platforms provide remote consultations, therapy guidance, and patient education, making it easier for individuals to engage with their treatment plans and track progress.

Core Growth Drivers

As of 2025, the thoracic outlet syndrome sector is undergoing an aggressive expansion phase, fueled predominantly by a growing trend of reclassifying previously "unknown" chronic shoulder and neck pain diagnoses into confirmed cases of thoracic outlet syndrome. This shift reflects a deeper understanding of the condition and an increased awareness among healthcare providers about the underlying causes of symptoms that were once attributed to vague or nonspecific diagnoses. As more patients receive accurate diagnoses, the demand for targeted treatments and specialized care rises correspondingly, driving significant growth in the market.

Emerging Opportunity Trends

The integration of ultrasound-guided Botox injections for precise muscle targeting has emerged as a significant trend driving growth in the thoracic outlet syndrome market. This innovative approach combines the therapeutic benefits of Botox with the accuracy of ultrasound imaging, enabling clinicians to deliver injections directly to the affected muscles with exceptional precision. By targeting specific muscle groups that contribute to nerve or vascular compression in thoracic outlet syndrome, this method enhances treatment efficacy while minimizing potential side effects associated with less targeted approaches.

Barriers to Optimization

A high rate of initial misdiagnosis presents a significant challenge to the effective treatment of thoracic outlet syndrome, and this issue may considerably hamper market growth. Because the symptoms of thoracic outlet syndrome often overlap with those of other musculoskeletal or neurological conditions, many patients experience delays in receiving an accurate diagnosis. This diagnostic complexity means that individuals frequently undergo multiple consultations and tests before their condition is correctly identified, prolonging the time before appropriate treatment can begin.

Detailed Market Segmentation

Based on deployment type, in 2025, hospital-based treatment settings dominate the Thoracic Outlet Syndrome (TOS) market, capturing the highest share of 54.59%. This substantial market presence reflects the critical role hospitals play in providing comprehensive care for TOS patients. The complexity of diagnosing and treating thoracic outlet syndrome, especially in its more severe forms, demands access to advanced medical technologies, multidisciplinary expertise, and surgical capabilities that are predominantly available in hospital environments. Hospitals offer an integrated platform where patients can receive thorough evaluations, sophisticated imaging, and specialized procedures, all of which are essential for effective management of this condition.

Based on application, in 2025, neurogenic thoracic outlet syndrome (TOS) stands out as the dominant application within the Thoracic Outlet Syndrome market, commanding over 55.12% of the market share. This significant proportion reflects the high prevalence and clinical importance of the neurogenic form of TOS, which is characterized by nerve compression in the thoracic outlet region. The dominance of this application underscores the need for specialized treatment approaches that address the complex neurological symptoms such as pain, numbness, and muscle weakness.

Based on technology/mode of action, in 2025, physical rehabilitation and manual therapy techniques dominate the market, capturing a substantial share of over 46%. This significant market presence can be attributed primarily to their status as the clinically recommended first-line treatment for many conditions. Healthcare professionals widely endorse these non-invasive therapies due to their proven effectiveness in improving patient outcomes while minimizing risks associated with more aggressive interventions.

Segment Breakdown

By Product Type

  • Pharmacological Treatments
  • NSAIDs
  • Muscle relaxants
  • Neuropathic pain medications
  • Physical Therapy & Rehabilitation Solutions
  • Postural correction programs
  • Nerve-gliding techniques
  • Surgical Intervention Tools & Devices
  • First rib resection tools
  • Scalenectomy instruments
  • Diagnostic Imaging & Evaluation Tools
  • MRI/CT imaging systems
  • Doppler ultrasound systems
  • Supportive & Adjunctive Treatment Devices
  • Orthotic braces
  • Pain management devices

By Deployment Type

  • Hospital-Based Treatment Settings
  • Outpatient Clinics/Ambulatory Centers
  • Home-Based & Remote Therapy Programs

By Application

  • Neurogenic Thoracic Outlet Syndrome
  • Venous Thoracic Outlet Syndrome
  • Arterial Thoracic Outlet Syndrome
  • Mixed/Non-specified TOS Conditions

By Technology

  • Physical Rehabilitation & Manual Therapy Techniques
  • Pharmacological Pain Management
  • Minimally Invasive Surgical Technologies
  • Imaging & Diagnostic Modalities
  • Nerve & Vascular Decompression Tools

By End-User

  • Hospitals & Specialty Care Centers
  • Physiotherapy & Rehabilitation Clinics
  • Outpatient Surgical Centers
  • Diagnostic Imaging Centers
  • Other End-Users

By Region

  • North America
  • The US
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia and New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds a commanding share of the global thoracic outlet syndrome (TOS) market, contributing an impressive 34.58% of the total revenue. This dominant position is largely attributed to the United States, where a centralized "center of excellence" model plays a pivotal role. This model consolidates high-acuity and complex TOS cases into specialized centers, allowing for concentrated expertise and advanced treatment protocols. This strategic organization not only improves patient outcomes but also attracts a significant volume of cases, further solidifying the region's leadership in managing thoracic outlet syndrome.
  • Additionally, the region's market dominance is reinforced by notably high procedural valuations. For instance, the average cost of Venous thoracic outlet syndrome surgery in North America reaches USD 114,824, which is substantially higher than the global average. This elevated pricing reflects the advanced healthcare infrastructure, cutting-edge technology, and specialized surgical expertise available in the region. The high valuation of these procedures contributes significantly to the overall revenue share North America commands in the TOS market.

Leading Market Participants

  • AngioDynamics
  • Becton Dickinson (BD)
  • Boston Scientific
  • Canon Medical Systems
  • Fujifilm Healthcare
  • GE HealthCare
  • Johnson and Johnson (DePuy Synthes)
  • Medtronic
  • Mindray
  • Philips Healthcare
  • Siemens Healthineers
  • Smith and Nephew
  • Stryker
  • Terumo Corporation
  • Zimmer Biomet
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Thoracic Outlet Syndrome Market

Chapter 2. Research Methodology & Research Framework

  • 2.1. Research Objective
  • 2.2. Product Overview
  • 2.3. Market Segmentation
  • 2.4. Qualitative Research
    • 2.4.1. Primary & Secondary Sources
  • 2.5. Quantitative Research
    • 2.5.1. Primary & Secondary Sources
  • 2.6. Breakdown of Primary Research Respondents, By Region
  • 2.7. Assumption for Study
  • 2.8. Market Size Estimation
  • 2.9. Data Triangulation

Chapter 3. Global Thoracic Outlet Syndrome Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Material Provider
    • 3.1.2. Manufacturer
    • 3.1.3. Distributor
    • 3.1.4. End User
  • 3.2. Industry Outlook
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
    • 3.5.2. Price Trend Analysis
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. By Segment/Region
    • 3.6.2. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Thoracic Outlet Syndrome Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product Type
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Pharmacological Treatments
          • 5.2.1.1.1.1. NSAIDs
          • 5.2.1.1.1.2. Muscle relaxants
          • 5.2.1.1.1.3. Neuropathic pain medications
        • 5.2.1.1.2. Physical Therapy & Rehabilitation Solutions
          • 5.2.1.1.2.1. Postural correction programs
          • 5.2.1.1.2.2. Nerve-gliding techniques
        • 5.2.1.1.3. Surgical Intervention Tools & Devices
          • 5.2.1.1.3.1. First rib resection tools
          • 5.2.1.1.3.2. Scalenectomy instruments
        • 5.2.1.1.4. Diagnostic Imaging & Evaluation Tools
          • 5.2.1.1.4.1. MRI/CT imaging systems
          • 5.2.1.1.4.2. Doppler ultrasound systems
        • 5.2.1.1.5. Supportive & Adjunctive Treatment Devices
          • 5.2.1.1.5.1. Orthotic braces
          • 5.2.1.1.5.2. Pain management devices
    • 5.2.2. By Deployment Type
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Hospital-Based Treatment Settings
        • 5.2.2.1.2. Outpatient Clinics/Ambulatory Centers
        • 5.2.2.1.3. Home-Based & Remote Therapy Programs
    • 5.2.3. By Application
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Neurogenic Thoracic Outlet Syndrome
        • 5.2.3.1.2. Venous Thoracic Outlet Syndrome
        • 5.2.3.1.3. Arterial Thoracic Outlet Syndrome
        • 5.2.3.1.4. Mixed/Non-specified TOS Conditions
    • 5.2.4. By Technology
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Physical Rehabilitation & Manual Therapy Techniques
        • 5.2.4.1.2. Pharmacological Pain Management
        • 5.2.4.1.3. Minimally Invasive Surgical Technologies
        • 5.2.4.1.4. Imaging & Diagnostic Modalities
        • 5.2.4.1.5. Nerve & Vascular Decompression Tools
    • 5.2.5. By End-User
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. Hospitals & Specialty Care Centers
        • 5.2.5.1.2. Physiotherapy & Rehabilitation Clinics
        • 5.2.5.1.3. Outpatient Surgical Centers
        • 5.2.5.1.4. Diagnostic Imaging Centers
        • 5.2.5.1.5. Other End-Users
    • 5.2.6. By Region
      • 5.2.6.1. Key Insights
        • 5.2.6.1.1. North America
          • 5.2.6.1.1.1. The U.S.
          • 5.2.6.1.1.2. Canada
          • 5.2.6.1.1.3. Mexico
        • 5.2.6.1.2. Europe
          • 5.2.6.1.2.1. Western Europe
  • 5.2.6.1.2.1.1. The UK
  • 5.2.6.1.2.1.2. Germany
  • 5.2.6.1.2.1.3. France
  • 5.2.6.1.2.1.4. Italy
  • 5.2.6.1.2.1.5. Spain
  • 5.2.6.1.2.1.6. Rest of Western Europe
          • 5.2.6.1.2.2. Eastern Europe
  • 5.2.6.1.2.2.1. Poland
  • 5.2.6.1.2.2.2. Russia
  • 5.2.6.1.2.2.3. Rest of Eastern Europe
        • 5.2.6.1.3. Asia Pacific
          • 5.2.6.1.3.1. China
          • 5.2.6.1.3.2. India
          • 5.2.6.1.3.3. Japan
          • 5.2.6.1.3.4. South Korea
          • 5.2.6.1.3.5. Australia & New Zealand
          • 5.2.6.1.3.6. ASEAN
          • 5.2.6.1.3.7. Rest of Asia Pacific
        • 5.2.6.1.4. Middle East & Africa
          • 5.2.6.1.4.1. UAE
          • 5.2.6.1.4.2. Saudi Arabia
          • 5.2.6.1.4.3. South Africa
          • 5.2.6.1.4.4. Rest of MEA
        • 5.2.6.1.5. South America
          • 5.2.6.1.5.1. Argentina
          • 5.2.6.1.5.2. Brazil
          • 5.2.6.1.5.3. Rest of South America

Chapter 6. North America Thoracic Outlet Syndrome Market Analysis

  • 6.1. Key Insights
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product Type
    • 6.2.2. By Deployment Type
    • 6.2.3. By Application
    • 6.2.4. By Technology
    • 6.2.5. By End-User
    • 6.2.6. By Country

Chapter 7. Europe Thoracic Outlet Syndrome Market Analysis

  • 7.1. Key Insights
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product Type
    • 7.2.2. By Deployment Type
    • 7.2.3. By Application
    • 7.2.4. By Technology
    • 7.2.5. By End-User
    • 7.2.6. By Country

Chapter 8. Asia Pacific Thoracic Outlet Syndrome Market Analysis

  • 8.1. Key Insights
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product Type
    • 8.2.2. By Deployment Type
    • 8.2.3. By Application
    • 8.2.4. By Technology
    • 8.2.5. By End-User
    • 8.2.6. By Country

Chapter 9. Middle East & Africa Thoracic Outlet Syndrome Market Analysis

  • 9.1. Key Insights
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product Type
    • 9.2.2. By Deployment Type
    • 9.2.3. By Application
    • 9.2.4. By Technology
    • 9.2.5. By End-User
    • 9.2.6. By Country

Chapter 10. South America Thoracic Outlet Syndrome Market Analysis

  • 10.1. Key Insights
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product Type
    • 10.2.2. By Deployment Type
    • 10.2.3. By Application
    • 10.2.4. By Technology
    • 10.2.5. By End-User
    • 10.2.6. By Country

Chapter 11. Company Profile (Company Overview, Financial Matrix, Key Product landscape, Key Personnel, Key Competitors, Contact Address, and Business Strategy Outlook)

  • 11.1. AngioDynamics
  • 11.2. Becton Dickinson (BD)
  • 11.3. Boston Scientific
  • 11.4. Canon Medical Systems
  • 11.5. Fujifilm Healthcare
  • 11.6. GE HealthCare
  • 11.7. Johnson and Johnson (DePuy Synthes)
  • 11.8. Medtronic
  • 11.9. Mindray
  • 11.10. Philips Healthcare
  • 11.11. Siemens Healthineers
  • 11.12. Smith and Nephew
  • 11.13. Stryker
  • 11.14. Terumo Corporation
  • 11.15. Zimmer Biomet
  • 11.16. Other Prominent Players

Chapter 12. Annexure

  • 12.1. List of Secondary Sources
  • 12.2. Key Country Markets- Macro Economic Outlook/Indicators